Patent ID: 11965035
Assignee: KYOWA KIRIN CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  G | IPC C  G

Claim 1:
2. The antibody or the antibody fragment thereof according to claim 1, wherein the antibody or fragment thereof is selected from the group consisting of the following (A) to (O):
(A) an antibody or fragment thereof in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 2 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 7;
(B) an antibody or fragment thereof in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 12 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 17;
(C) an antibody or fragment thereof in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 22 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 27;
(D) an antibody or fragment thereof in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 32 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 37;
(E) an antibody or fragment thereof in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 42 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 47;
(F) an antibody or fragment thereof in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 52 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 57;
(G) an antibody or fragment thereof in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 62 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 67;
(H) an antibody or fragment thereof in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 72 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 77;
(I) an antibody or fragment thereof in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 82 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 87;
(J) an antibody or fragment thereof in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 92 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 97;
(K) an antibody or fragment thereof in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 102 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 107;
(L) an antibody or fragment thereof in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 112 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 117;
(M) an antibody or fragment thereof in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 122 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 127;
(N) an antibody or fragment thereof in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 132 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 137; and
(O) an antibody or fragment thereof in which the amino acid sequence of VH comprises the amino acid sequence represented by SEQ ID NO: 142 and in which the amino acid sequence of VL comprises the amino acid sequence represented by SEQ ID NO: 147.